Clinical trials: Anemia in Children

Anemia of Chronic Kidney Disease

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

• Withdrawn
• Age: 4 months to 16 years
• Phase 3

This study will assess the safety and efficacy of once daily dosing of vadadustat for the treatment of pediatric participants with anemia of Chronic Kidney Disease (CKD) after conversion from an Erythropoiesis Stimulating Agent…

Trial name

CONVERSION (NCT05082571)

Testing

vadadustat

Where

United States

Sponsor

Akebia Therapeutics